CompoAtlas

OstroVit Glucosamine +MSM +Chondroitin

Food supplement declared in France, decision dated 13 May 2025

OstroVit Glucosamine +MSM +Chondroitin, from OstroVit sp. z o.o., is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: méthylsulfonate de méthane 600 mg per day, Sulfate de chondroïtine, Glucosamine sulfate 2 KCl. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
OstroVit sp. z o.o.
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Tablet
Daily dose
2 COMPRIMÉS

Declaration 268008, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Substances

NamePer day
méthylsulfonate de méthane600 mg

Other active ingredients

NamePer day
Sulfate de chondroïtinenot declared
Glucosamine sulfate 2 KClnot declared

Additives

E551, E470b, E460

Other ingredients

amidon

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • méthylsulfonate de méthane
    Read the warning, when it applies and the studies cited

    MSM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Kim et al. 2005).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “OstroVit Glucosamine +MSM +Chondroitin: composition and regulation”, https://compoatlas.com/en/supplements/products/268008-ostrovit-glucosamine-msm-chondroitin, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line